<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00027053</url>
  </required_header>
  <id_info>
    <org_study_id>NIAAAFRI13243</org_study_id>
    <secondary_id>R01AA013243</secondary_id>
    <secondary_id>NIH grant R01 AA013243</secondary_id>
    <nct_id>NCT00027053</nct_id>
  </id_info>
  <brief_title>Trazodone for Sleep Disturbance in Early Alcohol Recovery</brief_title>
  <acronym>SIESTA</acronym>
  <official_title>Trazodone for Sleep Disturbance - Early Alcohol Recovery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rhode Island Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Alcohol Abuse and Alcoholism (NIAAA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Rhode Island Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a randomized, double-blind clinical trial comparing trazodone (Desyrel) and
      placebo among sleep-disturbed, alcohol-dependent individuals shortly after discharge from an
      inpatient detoxification program. Subjects will undergo a baseline assessment and random
      assignment to trazodone or identical placebo for 12 weeks. All persons completing the alcohol
      detoxification at Stanley Street Treatment and Resources (SSTAR) will be screened. (SSTAR of
      Rhode Island provides detoxification services to non/underinsured persons of Rhode Island.)
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2002</start_date>
  <completion_date type="Actual">June 2006</completion_date>
  <primary_completion_date type="Actual">January 2006</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent days abstinent from alcohol (PDA)</measure>
    <time_frame>12 and 24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>sleep quality</measure>
    <time_frame>12 and 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Drinks per drinking day</measure>
    <time_frame>12 and 24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">173</enrollment>
  <condition>Alcoholism</condition>
  <arm_group>
    <arm_group_label>Trazodone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Trazodone</intervention_name>
    <description>50 to 150 mg qhs</description>
    <arm_group_label>Trazodone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Completed an alcohol detoxification program.

          -  Meets criteria for alcohol dependence.

          -  Meets criteria for sleep disturbance.

          -  If female of childbearing potential must be using adequate contraception.

          -  Has a location to which they will return after the initial research interview and a
             person they regularly contact.

          -  Speaks English sufficiently to understand instructions and assessment.

        Exclusion Criteria:

          -  Meets criteria for substance dependence for sedative/hypnotic drugs, stimulants,
             cocaine or opiates, or of organic brain disorder, bipolar disorder, schizophrenia,
             schizoaffective, schizophreniform, or paranoid disorder, or major depression.

          -  Current suicidality.

          -  Use of psychotropic, antidepressant, anxiolytic or antidipsogenic medication.

          -  Inability or refusal to terminate the use of proerectile agents, herbal medications or
             sleep medication for the study period.

          -  The presence of contraindications to the study medications, including
             pregnancy/lactation, ischemic heart disease, cardiac arrhythmias, priapism or
             hypotension.

          -  Presence of comorbid medical conditions associated with sleep disturbance including
             obstructive sleep apnea, poorly controlled diabetes mellitus or emphysema.

          -  Evidence of neuropsychological dysfunction.

          -  Probation/parole requirements that might interfere with participation in study.

          -  Inability to identify at least one contact person.

          -  Living on the street after detoxification (homeless persons living in a shelter,
             halfway house or other residence will not be excluded).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter D. Friedmann, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rhode Island Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rhode Island Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Friedmann PD, Rose JS, Swift R, Stout RL, Millman RP, Stein MD. Trazodone for sleep disturbance after alcohol detoxification: a double-blind, placebo-controlled trial. Alcohol Clin Exp Res. 2008 Sep;32(9):1652-60. doi: 10.1111/j.1530-0277.2008.00742.x. Epub 2008 Jul 8.</citation>
    <PMID>18616688</PMID>
  </results_reference>
  <verification_date>March 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2001</study_first_submitted>
  <study_first_submitted_qc>November 19, 2001</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2001</study_first_posted>
  <last_update_submitted>May 11, 2010</last_update_submitted>
  <last_update_submitted_qc>May 11, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 13, 2010</last_update_posted>
  <responsible_party>
    <name_title>Peter Friedmann</name_title>
    <organization>Rhode Island Hospital</organization>
  </responsible_party>
  <keyword>alcoholism</keyword>
  <keyword>alcohol dependence</keyword>
  <keyword>trazadone</keyword>
  <keyword>sleep</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alcoholism</mesh_term>
    <mesh_term>Dyssomnias</mesh_term>
    <mesh_term>Sleep Wake Disorders</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
    <mesh_term>Trazodone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

